PRMT1-mediated PGK1 Arginine Methylation Promotes Colorectal Cancer Glycolysis and Tumorigenesis

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2024 Feb 24

PMID 38402202

Authors

Hao Liu

Xintian Chen

Pengfei Wang

Miaolei Chen

Chuyin Deng

Xingyou Qian

Jin Bai

Zhongwei Li

Xiangyang Yu

Affiliations

Soon will be listed here.

Abstract

Many types of cancer cells, including colorectal cancer cells (CRC), can simultaneously enhance glycolysis and repress the mitochondrial tricarboxylic acid (TCA) cycle, which is called the Warburg effect. However, the detailed mechanisms of abnormal activation of the glycolysis pathway in colorectal cancer are largely unknown. In this study, we reveal that the protein arginine methyltransferase 1 (PRMT1) promotes glycolysis, proliferation, and tumorigenesis in CRC cells. Mechanistically, PRMT1-mediated arginine asymmetric dimethylation modification of phosphoglycerate kinase 1 (PGK1, the first ATP-producing enzyme in glycolysis) at R206 (meR206-PGK1) enhances the phosphorylation level of PGK1 at S203 (pS203-PGK1), which inhibits mitochondrial function and promotes glycolysis. We found that PRMT1 and meR206-PGK1 expression were positively correlated with pS203-PGK1 expression in tissues from colorectal cancer patients. Furthermore, we also confirmed that meR206-PGK1 expression is positively correlated with the poor survival of patients with colorectal cancer. Our findings show that PRMT1 and meR206-PGK1 may become promising predictive biomarkers for the prognosis of patients with CRC and that arginine methyltransferase inhibitors have great potential in colorectal cancer treatment.

Citing Articles

DUSP4 inhibited tumor cell proliferation by downregulating glycolysis via p-ERK/p-PGK1 signaling in ovarian cancer.

Xiong Y, Zhang X, Xie W, Yin Y, Qian Y, Ying X Cancer Cell Int. 2025; 25(1):87.

PMID: 40082940 PMC: 11908039. DOI: 10.1186/s12935-025-03722-0.

Pan-cancer investigation regarding the prognostic predictive and immunological regulation functions of PGK1 and experimental validation in esophageal squamous cell carcinoma.

Chen J, Wu X, Luo H, Wang D, Dong M, Wang Y Funct Integr Genomics. 2025; 25(1):54.

PMID: 40047969 DOI: 10.1007/s10142-025-01555-8.

Targeting the PRMT1-cGAS-STING signaling pathway to enhance the anti-tumor therapeutic efficacy.

Huang D, Rezaeian A, Wang J, Qi Y, Chen H, Inuzuka H J Cancer Biol. 2025; 5(2):44-60.

PMID: 40018367 PMC: 11867627. DOI: 10.46439/cancerbiology.5.064.

Exploring the Link Between Noncoding RNAs and Glycolysis in Colorectal Cancer.

Xu L, Shen Y, Zhang C, Shi T, Sheng X J Cell Mol Med. 2025; 29(4):e70443.

PMID: 39993964 PMC: 11850098. DOI: 10.1111/jcmm.70443.

Up-regulation of mA writer METTL14 inhibits tumorigenesis by suppressing glycolysis in colorectal cancer.

Li L, Zhang R, Li Y BMC Cancer. 2025; 25(1):305.

PMID: 39979838 PMC: 11844156. DOI: 10.1186/s12885-025-13532-2.

References

Yin X, Wang Y, Wang F, Feng W, Bai S, Zhao W . PRMT1 enhances oncogenic arginine methylation of NONO in colorectal cancer. Oncogene. 2021; 40(7):1375-1389. PMC: 7892343. DOI: 10.1038/s41388-020-01617-0. View

Sung H, Ferlay J, Siegel R, Laversanne M, Soerjomataram I, Jemal A . Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021; 71(3):209-249. DOI: 10.3322/caac.21660. View

Hu H, Zhu W, Qin J, Chen M, Gong L, Li L . Acetylation of PGK1 promotes liver cancer cell proliferation and tumorigenesis. Hepatology. 2016; 65(2):515-528. DOI: 10.1002/hep.28887. View

Shan Y, Klepeis J, Eastwood M, Dror R, Shaw D . Gaussian split Ewald: A fast Ewald mesh method for molecular simulation. J Chem Phys. 2005; 122(5):54101. DOI: 10.1063/1.1839571. View

Biggar K, Li S . Non-histone protein methylation as a regulator of cellular signalling and function. Nat Rev Mol Cell Biol. 2014; 16(1):5-17. DOI: 10.1038/nrm3915. View

Li Z, Wang D, Wang W, Chen X, Tang A, Hou P . Macrophages-stimulated PRMT1-mediated EZH2 methylation promotes breast cancer metastasis. Biochem Biophys Res Commun. 2020; 533(4):679-684. DOI: 10.1016/j.bbrc.2020.10.037. View

Liang C, Shi S, Qin Y, Meng Q, Hua J, Hu Q . Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer. Gut. 2019; 69(5):888-900. DOI: 10.1136/gutjnl-2018-317163. View

Ecker J, Benedetti E, Kindt A, Horing M, Perl M, Machmuller A . The Colorectal Cancer Lipidome: Identification of a Robust Tumor-Specific Lipid Species Signature. Gastroenterology. 2021; 161(3):910-923.e19. DOI: 10.1053/j.gastro.2021.05.009. View

Schmidt D, Patel R, Kirsch D, Lewis C, Vander Heiden M, Locasale J . Metabolomics in cancer research and emerging applications in clinical oncology. CA Cancer J Clin. 2021; 71(4):333-358. PMC: 8298088. DOI: 10.3322/caac.21670. View

10.

Madreiter-Sokolowski C, Klec C, Parichatikanond W, Stryeck S, Gottschalk B, Pulido S . PRMT1-mediated methylation of MICU1 determines the UCP2/3 dependency of mitochondrial Ca(2+) uptake in immortalized cells. Nat Commun. 2016; 7:12897. PMC: 5031806. DOI: 10.1038/ncomms12897. View

11.

Fong J, Pignata L, Goy P, Kawabata K, Chun-Wei Lee S, Koh C . Therapeutic Targeting of RNA Splicing Catalysis through Inhibition of Protein Arginine Methylation. Cancer Cell. 2019; 36(2):194-209.e9. PMC: 7194031. DOI: 10.1016/j.ccell.2019.07.003. View

12.

Liu J, Bu X, Chu C, Dai X, Asara J, Sicinski P . PRMT1 mediated methylation of cGAS suppresses anti-tumor immunity. Nat Commun. 2023; 14(1):2806. PMC: 10188589. DOI: 10.1038/s41467-023-38443-3. View

13.

Li Z, Yong H, Wang W, Gao Y, Wang P, Chen X . GSK3326595 is a promising drug to prevent SARS-CoV-2 Omicron and other variants infection by inhibiting ACE2-R671 di-methylation. J Med Virol. 2022; 95(1):e28158. PMC: 9537780. DOI: 10.1002/jmv.28158. View

14.

Cliff M, Bowler M, Varga A, Marston J, Szabo J, Hounslow A . Transition state analogue structures of human phosphoglycerate kinase establish the importance of charge balance in catalysis. J Am Chem Soc. 2010; 132(18):6507-16. DOI: 10.1021/ja100974t. View

15.

Zhao G, Yuan H, Li Q, Zhang J, Guo Y, Feng T . DDX39B drives colorectal cancer progression by promoting the stability and nuclear translocation of PKM2. Signal Transduct Target Ther. 2022; 7(1):275. PMC: 9381590. DOI: 10.1038/s41392-022-01096-7. View

16.

Patel S, Karlitz J, Yen T, Lieu C, Boland C . The rising tide of early-onset colorectal cancer: a comprehensive review of epidemiology, clinical features, biology, risk factors, prevention, and early detection. Lancet Gastroenterol Hepatol. 2022; 7(3):262-274. DOI: 10.1016/S2468-1253(21)00426-X. View

17.

Nie H, Ju H, Fan J, Shi X, Cheng Y, Cang X . O-GlcNAcylation of PGK1 coordinates glycolysis and TCA cycle to promote tumor growth. Nat Commun. 2020; 11(1):36. PMC: 6946671. DOI: 10.1038/s41467-019-13601-8. View

18.

Li Q, Zhang L, Yang Q, Li M, Pan X, Xu J . Thymidine kinase 1 drives hepatocellular carcinoma in enzyme-dependent and -independent manners. Cell Metab. 2023; 35(6):912-927.e7. DOI: 10.1016/j.cmet.2023.03.017. View

19.

Yao B, Gui T, Zeng X, Deng Y, Wang Z, Wang Y . PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling. Genome Med. 2021; 13(1):58. PMC: 8048298. DOI: 10.1186/s13073-021-00871-5. View

20.

Li Z, Wang D, Lu J, Huang B, Wang Y, Dong M . Methylation of EZH2 by PRMT1 regulates its stability and promotes breast cancer metastasis. Cell Death Differ. 2020; 27(12):3226-3242. PMC: 7853151. DOI: 10.1038/s41418-020-00615-9. View